PFE Pfizer
- 28.010
- -0.170-0.60%
- 27.970
- -0.040-0.14%
Pfizer News
Cantor Picks 14 Undervalued Biotech Stocks Worth a Second Look
Pfizer, AstraZeneca Announce New Investments of Nearly US$1b in France
PARIS (May 12): Leading healthcare companies Pfizer and AstraZeneca announced on Sunday, new investments in France worth a total of nearly US$1 billion, ahead of the start of this year's annual "Choose France" business summit.
Express News | Pfizer : Announces 500 Mln Euros Investment in France as Part of This Year's 'choose France' Business Summit
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
A Struggling Pfizer Looks for Help From a Wall Streeter
Andrew Baum, a Citigroup drug-company analyst and its head of global healthcare, hasn't had a Buy rating on Pfizer shares for over a decade, and he has pulled his target price down as the stock has fallen. But on Monday, Pfizer said it was hiring him to be its chief strategy and innovation officer.
Top Stock Reports for Amazon.com, Visa & Pfizer
Pfizer Options Spot-On: On May 10th, 119.35K Contracts Were Traded, With 3.21 Million Open Interest
On May 10th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 119.35K options for the day, of which put options accounted for 60.97% of the total transactions, and call o
Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets
It's been a quiet week in the markets, marked by a dearth of major economic news and a consistent flow of positive indicators from the first-quarter earnings season.As of May 7, 424 companies in the S
Express News | NYSE Order Imbalance 397936.0 Shares on Buy Side
Novavax CEO on Sanofi Deal: 'This Is a New Chapter in the History of Our Company'
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Novavax Hits a 52-week High as Sanofi Deal Prompts J.P. Morgan Upgrade
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
The Food and Drug Administration (FDA) notified Moderna Inc (NASDAQ:MRNA) on Friday that its review of a new vaccine has been delayed.The agency, citing administrative constraints, does not expect to
FDA Delays Decision on Moderna RSV Shot by 3 Weeks -- Barrons.com
By Josh Nathan-Kazis The Food and Drug Administration has pushed back the release of its decision on approval of Moderna's respiratory syncytial virus vaccine by up to three weeks due to "administrat
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps.
The two companies will also work on a shot that combines Covid-19 and flu vaccines.
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.Looking at options history for Pfizer (NYSE:PFE) we detected 27 trades.If we consider the specifics of each trade,
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Pfizer Options Spot-On: On May 9th, 179.62K Contracts Were Traded, With 3.21 Million Open Interest
On May 9th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 179.62K options for the day, of which put options accounted for 41.25% of the total transactions, and call op
Analysis
Price Target
No Data
